Previous Article | Next Article 
Journal of Virology, February 2001, p. 1697-1707, Vol. 75, No. 4
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.4.1697-1707.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Murine Cytomegalovirus Open Reading Frame M27 Plays
an Important Role in Growth and Virulence in Mice
Gerardo
Abenes,
Manfred
Lee,
Erik
Haghjoo,
Tuong
Tong,
Xiaoyan
Zhan, and
Fenyong
Liu*
Program in Infectious Diseases and Immunity,
School of Public Health, University of California, Berkeley,
California 94720
Received 11 September 2000/Accepted 22 November 2000
 |
ABSTRACT |
Using a Tn3-based transposon mutagenesis approach, we
have generated a pool of murine cytomegalovirus (MCMV) mutants. In this study, one of the mutants, RvM27, which contained the transposon sequence at open reading frame M27, was characterized both in tissue
culture and in immunocompetent BALB/c mice and immunodeficient SCID
mice. Our results suggest that the M27 carboxyl-terminal sequence is
dispensable for viral replication in vitro. Compared to the wild-type
strain and a rescued virus that restored the M27 region, RvM27 was
attenuated in growth in both BALB/c and SCID mice that were
intraperitoneally infected with the viruses. Specifically, the titers
of RvM27 in the salivary glands, lungs, spleens, livers, and kidneys of
the infected SCID mice at 21 days postinfection were 50- to 500-fold
lower than those of the wild-type virus and the rescued virus.
Moreover, the virulence of the mutant virus appeared to be attenuated,
because no deaths occurred among SCID mice infected with RvM27 for up
to 37 days postinfection, while all the animals infected with the
wild-type and rescued viruses died within 27 days postinfection. Our
observations provide the first direct evidence to suggest that a
disruption of M27 expression results in reduced viral growth and
attenuated viral virulence in vivo in infected animals. Moreover, these
results suggest that M27 is a viral determinant required for optimal
MCMV growth and virulence in vivo and provide insight into the
functions of the M27 homologues found in other animal and human CMVs as well as in other betaherpesviruses.
 |
INTRODUCTION |
Human cytomegalovirus (HCMV) is an
important opportunistic pathogen affecting individuals whose immune
functions are compromised or immature (4, 29). The virus
is a leading cause of retinitis-associated blindness and other
debilitating conditions such as pneumonia and enteritis among AIDS
patients (15, 35, 45, 46). Moreover, it causes mental and
behavioral dysfunctions in children who were infected in utero
(14). HCMV also accounts for serious posttransplant complications among allograft recipients undergoing
immunosuppressive treatment (4).
HCMV contains a linear DNA genome of 230 kb that is
predicted to encode more than 200 proteins (7). This virus
belongs to the family of betaherpesviruses whose members have
the common characteristic of being highly species specific
(4, 29). This characteristic precludes the use of
experimental animals in studying HCMV infections. There is
currently no animal model suitable for studying HCMV
pathogenesis. Consequently, other related model systems involving
animal CMVs, such as murine, rat, guinea pig, and primate CMVs, have to
be used to provide insight into the tissue tropism, virulence, latency,
and reactivation of HCMV (19, 22, 29).
Murine CMV (MCMV) is a natural pathogen of mice that possesses a
remarkable biological resemblance to HCMV. The two viruses have
extensive homology in many of their genes (7, 38), and they exhibit a strikingly similar pathogenesis in their respective hosts (19, 22, 29). Comparison of the complete
genomic sequence of HCMV and MCMV revealed that more than 75 open reading frames in these two viruses show extensive sequence
homology (7, 38). Both viruses initiate acute infection by
targeting common organs and tissues in their hosts, after which
infection typically progresses to persistence, latency, and periodic
reactivation (19, 22, 29). The similarities between the
two viruses, plus the availability of a vast pool of genetically
defined strains of mice, have made MCMV an excellent model system for
studying the biology of CMV infections and virus-host interactions and
providing insight into the mechanism of HCMV pathogenesis. An
understanding of the function of MCMV-encoded genes, especially those
that are highly homologous to those encoded by HCMV, in mice is
expected to provide insight into the functions of their HCMV
counterparts in viral pathogenesis in humans.
Numerous studies have demonstrated the power of mutagenesis in studying
the functions of herpesvirus genes (see reviews in references 29
and 41). By specifically mutagenizing a gene and then analyzing
the phenotype of the mutated virus both in vitro in tissue culture and
in vivo in animal models, it has been possible to map on the
herpesvirus genome specific viral functions, such as those involved in
replication, tropism, virulence, and other biological phenomena such as
viral immune evasion. The construction of herpesvirus mutants was first
reported using site-directed homologous recombination and
transposon-mediated insertional mutagenesis (21, 30, 37, 40,
55). Furthermore, methods using overlapping cosmid DNA fragments
to generate mutants of HCMV and other herpesviruses have also been
reported (8, 10, 23, 50, 51). More recently, the MCMV
genome as well as the genomes of other herpesviruses have been cloned
into a bacterial artificial chromosome and viral mutants have been
successfully generated from the bacterial artificial chromosome-based
viral genome by a bacterial mutagenesis procedure (3, 5, 12, 28,
43, 47-49, 54). These studies have greatly facilitated the
identification of the functions of viral genes in tissue culture and in animals.
Many of the CMV genes have been found to be dispensable for growth in
cultured cells. Their presence in the viral genome indicates that they
are probably needed to perform functions involved in modulating viral
interactions with the respective human or animal hosts. For example,
MCMV open reading frame M83, which encodes one of the most abundant
proteins found in the tegument and is dispensable for viral replication
in vitro, is required for efficient viral replication and virulence in
vivo (9, 31, 57). Thus, studies of viral mutants carrying
mutations in genes found to be dispensable in tissue culture are
valuable for understanding the function of the genes in viral
pathogenesis and virus-host interactions.
We have previously reported on the use of a Tn3-based
transpositional mutagenesis approach to disrupt genes in the MCMV
genome and the construction of recombinant viruses that carry the
disrupted genes (56, 57). In this approach, the transposon
is randomly inserted into the MCMV genomic DNA fragments in a
plasmid library in Escherichia coli. Regions bearing an
insertion mutation are then transferred to the MCMV genome by
homologous recombination between the plasmid library and purified MCMV
genomic DNA in NIH 3T3 cells. In the present study, we have
characterized an MCMV mutant, RvM27, which contains a transposon
insertion in open reading frame M27, a homologue of the HCMV UL27 open
reading frame (7, 38). The function of M27 as well as that
of UL27 is currently unknown. Indeed, the M27 and UL27 open reading
frames have not been extensively characterized either transcriptionally
or translationally. Our results provide the first direct evidence to
suggest that a disruption of open reading frame M27 leads to
attenuation of viral virulence and deficient growth in vivo. When the
mutant virus was used to infect immunocompetent BALB/c mice and
immunodeficient SCID mice intraperitoneally, the viral titers in the
salivary glands, lungs, spleens, livers, and kidneys were significantly lower than those in mice inoculated with the wild-type virus and a
revertant virus that rescued the mutation and restored the M27 open
reading frame. Moreover, the viral mutant was attenuated in killing
SCID mice. These results suggest that M27 is a viral determinant for
MCMV pathogenicity and is required for optimal viral virulence and
growth in vivo.
 |
MATERIALS AND METHODS |
Cells and viruses.
The Smith strain of MCMV, mouse NIH 3T3
cells, and STO cells were obtained from the American Type Culture
Collection (Manassas, Va.). The Smith strain, viral mutant RvM27, and
rescued virus RqM27 were grown in NIH 3T3 cells (ATCC CRL 1658) in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10%
Nu-Serum (Collaborative Research Inc., Waltham, Mass.), 100 U of
penicillin and 100 µg of streptomycin per ml, and 0.1 mM MEM amino
acids (Gibco-BRL, Grand Island, N.Y.). STO cells (ATCC CRL 1503) were grown in DMEM supplemented with 10% fetal bovine serum (Gibco-BRL) plus 100 U of penicillin and 100 µg of streptomycin per ml. Cell cultures were maintained at 37°C in a humidified incubator with 5%
CO2.
Animals.
The immunocompetent BALB/c-ByJ mice and
immunodeficient CB17 SCID mice were purchased from the Jackson
Laboratory (Bay Harbor, Maine) and National Cancer Institute
(Frederick, Md.), respectively, and used at 3 to 5 weeks of age. Mice
were acclimatized for 2 to 3 days prior to infection. Mice were housed
in microisolator cages and fed and watered ad libitum throughout the experiments.
Construction of MCMV mutants by transposon-based shuttle
mutagenesis and generation of rescued virus.
The transposon
Tn3gpt, which is derived from the Tn3 transposon
from E. coli (6, 42, 44), contains the
expression cassette encoding guanine phosphoribosyltransferase
(gpt) (which contains the gpt coding sequence
driven by a promoter and a transcription termination signal) and an
additional transcription termination site (Fig.
1A) (56). Isolation of viral
genomic DNA, construction of an MCMV genomic subclone
pool, and transposon-based shuttle mutagenesis to generate a pool of
MCMV DNA fragments (MCMV-Tn3gpt) containing a
Tn3gpt insertion were performed as described by Zhan et al. (56). To generate a pool of MCMV mutants
that contained the transposon sequence, full-length MCMV
genomic DNA and plasmid DNA containing MCMV-Tn3gpt
fragments were cotransfected into NIH 3T3 cells using a calcium
phosphate precipitation protocol (Gibco-BRL, Grand Island, N.Y.). The
recombinant MCMV was selected in the presence of mycophenolic acid (25 µg/ml; Gibco-BRL) and xanthine (50 µg/ml) (Sigma, St. Louis, Mo.)
and plaque purified three times following the protocol described
previously (57). To confirm the integration of the
transposon in the viral genome and identify the genes that contained
the transposon insertion, viral DNA was purified and directly sequenced
using the primer FL110OPRIM (5'-GCAGGATCCTATCCATATGAC-3') by
the Fmol cycle sequencing kit (Promega, Inc., Madison, Wis.).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Schematic representation of the structure of the
transposon construct used for mutagenesis. Tet, tetracycline resistance
gene; gpt gene that encodes guanine
phosphoribosyltransferase (gpt); poly(A), transcription
termination signal. (B) Location of the transposon insertion in the
recombinant virus. The transposon sequence is shown as a solid bar,
while the coding sequence of open reading frame M27 is represented by
an open arrow. The orientation of the arrow represents the
direction of translation and transcription predicted from the
nucleotide sequence (38). The numbers represent the sizes
of the DNA fragments of the viruses that were generated by digestion
with HindIII (H) or EcoRI (E). (C) Southern
analyses of the recombinant viruses. The DNA fractions were isolated
from cells infected with the wild-type (WT) virus, RvM27, or RqM27. The
DNA samples (10 µg) were digested with either HindIII
or EcoRI, separated on 1% agarose gels, transferred to a
Zeta-Probe membrane, and hybridized to a DNA probe. The probe used for
the analyses was the plasmid that contained the MCMV DNA fragment
carrying the transposon sequence.
|
|
To construct the rescued virus RqM27, the full-length genomic
DNA of RvM27 was isolated from virus-infected cells as described
previously (
57). The DNA sequence that contained the
coding
sequence of M27 was generated by PCR using MCMV genomic
DNA as
the template, the 5' primer M27-sense
(5'-ACCTGTAGCTAGACCCGATG-3'),
and the 3' primer
M27-antisense (5'-TGCGTCCAGCGCGACATGGA-3').
The PCR product
that contained the M27 coding sequence (3 to 10
µg) and the
full-length intact RvM27 genomic DNA (8 to 12 µg)
were
subsequently cotransfected into mouse STO cells using a calcium
phosphate precipitation protocol (Gibco-BRL). The recombinant
virus was
selected in STO cells in the presence of 6-thioguanine
(25 µg/ml;
Sigma) and purified by six rounds of amplification
and plaque
purification, following the protocol described previously
(
17). For each cotransfection, several viral plaques were
picked
and expanded. Viral stocks were prepared by growing the viruses
in roller bottles of NIH 3T3
cells.
Northern and Southern analyses of recombinant viruses.
For
Northern blot analysis, cells were infected with virus at a
multiplicity of infection (MOI) of 5 and harvested at different time
points postinfection. In the experiments to assay the expression of
immediate-early transcripts, cells were treated with cycloheximide (100 µg/ml; Sigma) and then infected with viruses and harvested at 6 h postinfection (25). Total cytoplasmic RNA was isolated from NIH 3T3 cells infected with the viruses as described previously (24). Viral RNAs were separated in 0.8 to 1% agarose gels
that contained formaldehyde, transferred to a nitrocellulose membrane, hybridized with the 32P-radiolabeled DNA probes that
contained the MCMV sequences, and finally analyzed with a STORM840
phosphoimager. The DNA probes used for Northern analyses were generated
by PCR using viral DNA as the template and radiolabeled with a random
primer synthesis kit in the presence of [
-32P]dCTP
(Boehringer Mannheim, Indianapolis, Ind.). The 5' PCR primers used in
the construction of DNA probes for the Northern analysis of the M27 and
M25 transcripts were M27-5'NDS (5'-GGATTCGTCGGGCTCCGACG-3') and M25-5'NDS (5'-CGACGACGATGACGACGATG-3'),
respectively. The 3' PCR primers used were M27-3'NDS
(5'-CCGCTCCACCACAAACTCGG-3') and M25-3'NDS
(5'-GTCCTGACCGCTCACTACAC-3'), respectively.
For Southern blot analysis, viral DNA was purified from NIH 3T3 cells
infected with the viruses as described previously (
52,
56). Briefly, cells that exhibited 100% cytopathic effect were
washed with phosphate-buffered saline and then lysed using a solution
that contained sodium dodecyl sulfate and proteinase K. The
genomic
DNA was purified by extraction with phenol-chloroform
followed
by precipitation with 2-propanol. The DNA was then digested
with
HindIII or
EcoRI, separated on agarose
gels (0.8 to 1%), transferred
to Zeta-Probe nylon membranes (Bio-Rad,
Hercules, Calif.), hybridized
with the
32P-radiolabeled DNA
probes that contained the transposon and the
MCMV M27 sequence, and
finally analyzed with a STORM840 phosphoimager
(
57). The
labeled DNA probes were prepared by random primer
synthesis (Boehringer
Mannheim).
Analysis of growth of viruses in vitro.
The growth kinetics
of the viruses was determined as described previously
(57). Briefly, NIH 3T3 cells grown to 60 to 75% confluence were inoculated with virus at an MOI of either 0.5 or 5. At
0, 1, 2, 4, and 7 days postinfection, the infected cells together with
medium were harvested, and an equal volume of 10% skim milk was added
before sonication. Virus titer was determined by plaque assays in NIH
3T3 cells. The titers reported are the averages of triplicate experiments.
Analysis of viral virulence in SCID mice.
The virulence of
the viruses was studied by determining the mortality rates of animals
infected with the Smith strain, RvM27, or RqM27. Male CB17 SCID mice (4 to 6 weeks old, five animals per group) were infected intraperitoneally
with 104 PFU of each virus. The viral inoculum used for the
infection of animals were prepared by growing the viruses in NIH 3T3
cells. The animals were observed twice daily, the mortality of the
infected animals was monitored for at least 41 days postinfection, and the survival rates for each virus were determined.
Analysis of growth of viruses in BALB/c and SCID mice.
The
viral inoculum used for the infection of animals were prepared by
growing the viruses in NIH 3T3 cells. Male BALB/c-ByJ mice (3 to 4 weeks old) or CB17 SCID mice (4 to 6 weeks old) were infected
intraperitoneally with 104 PFU of each virus. The infected
animals were sacrificed at 1, 3, 7, 10, 14, and 21 days
postinoculation. Moreover, the salivary glands were also collected from
the BALB/c mice at 28 and 35 days postinfection. For each time point,
at least three animals were used as a group and infected with the same
virus. The salivary glands, lungs, spleens, livers, and kidneys were
harvested and sonicated as a 10% (wt/vol) suspension in a 1:1 mixture
of DMEM and 10% skim milk. The sonicates were stored at
80°C until
plaque assays were performed.
Plaque assays were performed in NIH 3T3 cells plated overnight to about
60 to 75% confluence in six-well cluster plates (Costar,
Corning,
N.Y.). Tenfold serial dilutions of virus in 1 ml of DMEM
were
inoculated onto each well of NIH 3T3 cells. After 90 min
of incubation
at 37°C in a 5% CO
2 incubator, the cells were washed
with DMEM and then overlaid with DMEM containing 1% low-melt-point
agarose (Sigma). Viral plaques were counted after 4 to 6 days
under an
inverted microscope. Each sample was assayed in triplicate,
and the
titer of the sample was expressed as the average of the
three values.
Viral titers were recorded as PFU per milliliter
of organ homogenate.
The limit of virus detection in the organ
homogenates was 10 PFU/ml of
the sonicated mixture. Those samples
that were negative at a
10
1 dilution were designated as having a titer of 10 (10
1) PFU/ml.
 |
RESULTS |
Construction of an MCMV mutant containing the transposon insertion
at open reading frame M27 and the rescued virus that restored the
mutation.
We have constructed a pool of MCMV mutants using an
E. coli Tn3-based transposon mutagenesis system
(57). In our mutagenesis procedure, an MCMV
genomic library containing a randomly inserted transposon
(designated Tn3gpt) in each viral DNA fragment was first
generated using a shuttle mutagenesis method described previously (56). Such a pool of MCMV genomic fragments
containing randomly inserted Tn3gpt sequence were then
cotransfected with the full-length genomic DNA of the wild-type
virus (Smith strain) into mouse NIH 3T3 cells, in which
homologous recombination occurred. The cells that harbored the
progeny viruses expressing the gpt gene were selected
for growth in the presence of mycophenolic acid and xanthine (17, 32, 52). Individual recombinant viruses were isolated after multiple rounds of selection and plaque purification. The location of the inserted transposon was determined by directly sequencing the genomic DNA of the recombinants. One of the
recombinant viruses, designated RvM27, contained the transposon
insertion within open reading frame M27 (Fig. 1B). Figure 1A shows the
structure of the transposon used to generate the MCMV mutant. The
transposon contains the expression cassette consisting of the
gpt gene driven by a promoter and a transcription
termination signal and an additional transcription termination site,
which allows the selection of MCMV mutants in mammalian cells and the
truncation of the transcript expressed from the disrupted gene
(56). The gpt expression cassette was inserted
so that its transcription termination site functioned in the opposite
direction from the other poly(A) signal in the transposon (Fig. 1A).
Such a design would ensure that the transcription of the targeted gene
is disrupted without altering the expression of nearby genes that may
share a poly(A) signal with the disrupted gene. Sequence analyses of
the junction between the transposon and the viral sequence in RvM27
revealed that the transposon is located at nucleotide position 32863 (amino acid residue 477 of the 682-amino-acid-long open reading frame)
in reference to the genome sequence of the wild-type Smith strain
(38) (Fig. 1B and data not shown).
It has been observed that spontaneous mutations within the viral
genome, including deletion and rearrangement, can be generated
during
construction of viral mutants using a homologous recombination
approach
(
26) (G. Abenes, X. Zhan, M. Lee, and F. Liu, unpublished
results). To exclude the possibility that the phenotype observed
with
RvM27 might be due to some other adventitious mutations in
the genome
of the viral mutant rather than to the disruption of
the M27 open
reading frame, a rescued virus, RqM27, was derived
from RvM27 by
restoration of the wild-type M27 sequence in RvM27
(Fig.
1B).
Construction of the rescued virus was carried out using
a procedure
similar to that used for generating the viral mutant.
A DNA fragment
that contained the M27 coding region was cotransfected
with the
full-length RvM27 genomic DNA into mouse STO cells to
allow
homologous recombination to occur. The cells that harbored
the progeny
viruses were allowed to grow in the presence of 6-thioguanine,
which
selects against
gpt expression (
17,
32). The
rescued
virus, designated RqM27, which did not express the
gpt-encoded
protein and no longer contained the transposon,
was isolated after
multiple rounds of selection and plaque
purification.
Characterization of mutant RvM27 and rescued virus RqM27
in tissue culture.
The genomic structures of the
recombinant viruses were examined by Southern blot hybridization and
compared to that of the wild-type Smith strain, using a DNA probe
containing both the transposon and the viral sequences (Fig. 1B and
1C). The sizes of the RvM27 hybridized DNA fragments (Fig. 1C) were
consistent with the predicted digestion patterns of the viral mutant
based on the MCMV genomic sequence (38) and the
location of the transposon insertion in the viral genome as determined
by sequence analysis (Fig. 1B). The restriction enzyme digestion
patterns of the regions of the RvM27 genomic DNA other than the
transposon insertion site appeared to be identical to those of the
parental Smith strain, as indicated by ethidium bromide staining of the
digested DNAs (data not shown). This observation suggested that regions
of the viral genome other than the region containing the transposon
insertion remained intact in this MCMV mutant. Analysis of the RqM27
DNA samples digested with HindIII and EcoRI
showed that the sizes of the hybridized DNA fragments for the rescued
virus were identical to those of the hybridized fragments for strain
Smith and were different from those for RvM27 (Fig. 1B and C, lanes 2 and 5). These results indicate that RqM27 did not contain the
transposon sequence and that the M27 region was restored (Fig. 1C,
lanes 2 and 5). Moreover, the restriction enzyme digestion patterns of
the regions of the rescued RqM27 genomic DNA samples other than
the M27 region appeared to be identical to those of the parental RvM27,
as indicated by ethidium bromide staining of the digested DNAs (data
not shown). This observation suggested that the regions of the genome
of RqM27 other than the M27 region remained intact and were
identical to those of RvM27. Thus, RqM27 represents a rescued
virus derived from RvM27.
Transcription from the target M27 region is expected to be disrupted
due to the presence of the two transcription termination
signals within
the transposon (Fig.
1A). In particular, the region
of the M27 open
reading frame downstream from the transposon insertion
site is not
expected to be expressed. To determine whether this
is the case,
cytoplasmic RNAs were isolated from cells infected
with the mutant
virus at different time points (4, 12, and 24
h) postinfection.
Northern analysis was carried out to examine
the expression of the
transcripts from the M27 open reading frame
downstream from the
transposon insertion site (Fig.
2). The
probe
(the 3' probe) used in the Northern analyses contained the DNA
sequence complementary to the 3' M27 coding region that is within
200 nucleotides downstream from the site of the transposon insertion.
An
RNA species of about 3 kb was detected in the RNA fractions
isolated
from cells that were infected with the wild-type Smith
strain (Fig.
2,
lane 1). This ~3-kb RNA species was also readily
detected from cells
infected with the Smith strain using a DNA
probe (the 5' probe)
complementary to the 5'-terminal sequence
of M27 open reading frame
that is within 300 nucleotides downstream
from the M27 translation
initiation site (data not shown) (
56).
These results
suggest that this ~3-kb RNA species represents the
transcript
expressed from the M27 open reading frame. However,
this transcript was
not detected in the RNA fractions isolated
from cells infected with
RvM27 when the 3' probe, which is complementary
to the M27 coding
region downstream from the site of the transposon
insertion, was used
in the Northern analyses (Fig.
2, lane 3).
These observations suggest
that transcription from the M27 region
downstream from the transposon
insertion site was disrupted in
RvM27. Meanwhile, expression of the
transcript was found in the
RNA fractions from cells infected with the
rescued virus RqM37
(Fig.
2, lane 2). The level of MCMV M25 transcript
(
11,
57)
was used as the internal control for expression
of the M27 transcript.
As shown in Fig.
2, the levels of the M25
transcript detected
in cells that were infected with RvM27 and RqM27
were found to
be similar to that of M25 transcript in cells infected
with the
Smith strain (Fig.
2, lanes 5 to 8). Thus, the transposon
insertion
in RvM27 appeared to disrupt the transcript expressed from
the
M27 open reading frame, whereas the wild-type expression of the
transcript was restored in RqM27. In order to determine whether
these
viruses had any growth defects in vitro, experiments were
carried out
to study the growth rates of the recombinant viruses
in NIH 3T3 cells.
Cells were infected with these viruses at both
low and high MOIs, and
their growth rates were assayed in triplicate
experiments. No
significant difference was found in growth rates
among RvM27, RqM27,
and the Smith strain (Fig.
3).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 2.
Northern analyses of RNA fractions isolated from cells
that were mock infected (lanes 4 and 8) or infected with the wild-type
(WT) virus (lanes 1 and 5), RqM27 (lanes 2 and 6), and RvM27 (lanes 3 and 7). A total of 5 × 106 NIH 3T3 cells were
infected with each virus at an MOI of 5 PFU per cell, and cells were
harvested at 24 h postinfection. RNA samples (20 µg in lanes 1 to 4 and 10 µg in lanes 5 to 8) were separated on agarose gels
that contained formaldehyde, transferred to a nitrocellulose membrane,
and hybridized to a 32P-radiolabeled probe that contained
the sequence of M27 (M27 probe) (lanes 1 to 4) or M25 (M25 probe)
(lanes 5 to 8). Sizes are shown in kilobase pairs.
|
|

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 3.
In vitro growth of MCMV mutants in tissue culture. Mouse
NIH 3T3 cells were infected with each virus at an MOI of either 0.5 PFU
(A) or 5 PFU (B) per cell. At 0, 1, 2, 4, and 7 days postinfection,
cells and culture medium were harvested and sonicated. The viral titers
were determined by plaque assays on NIH 3T3 cells. The titers represent
the averages obtained from triplicate experiments. The standard
deviation is indicated by the error bars.
|
|
Deficient growth of recombinant virus RvM27 in immunocompetent
animals.
To determine whether disruption of M27 adversely affects
viral replication in vivo, BALB/c-ByJ mice were injected
intraperitoneally with 104 PFU of RvM27, RqM27, or the
wild-type Smith strain. The viral inocula used for the infection of
animals were prepared by growing the viruses in NIH 3T3 cells. At 1, 3, 7, 10, 14, and 21 days postinfection, salivary glands, lungs,
spleens, livers, and kidneys were harvested, and the viral particles in
these five organs were counted on NIH 3T3 cells. Moreover, the titers
of viruses from the salivary glands at 28 and 35 days postinfection
were also determined. These organs are among the major targets for MCMV infection (4, 19, 22, 29). At 21 and 28 days
postinfection, the titers of RvM27 found in the salivary glands were
about 500-fold lower than those of the Smith strain (Fig.
4A). Moreover, the peak titers
of RvM27 found in the lungs, spleens, livers, and kidneys of the
infected animals at 10 days postinfection were about 10-, 2-, 10-, and
5-fold lower, respectively, than the titers in the same organs from
animals infected with the Smith strain (Fig. 4B to E). In
contrast, the titers of the rescued virus RqM27 found in the same
organs were similar to the titers of the Smith strain. Previous studies
have shown that the presence of the transposon sequence per se
within the viral genome does not significantly affect viral
growth in BALB/c mice in vivo (57). Thus, these results
suggest that the growth deficiency of RvM27 in the organs examined is
due to the disruption of M27 and that open reading frame M27 is
important for optimal viral growth in vivo, at least in these organs in
BALB/c mice.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Titers of MCMV mutants in the salivary glands (A), lungs
(B), spleens (C), livers (D), and kidneys (E) of infected BALB/c mice.
BALB/c-Byj mice were infected intraperitoneally with 104
PFU of each virus. At 1, 3, 7, 10, 14, and 21 days postinfection, the
animals (three mice per group) were sacrificed. The salivary glands,
lungs, spleens, livers, and kidneys were collected and sonicated.
Moreover, the salivary glands were also collected from animals at 28 and 35 days postinfection. The viral titers in the tissue homogenates
were determined by standard plaque assays in NIH 3T3 cells. The limit
of detection was 10 PFU/ml of tissue homogenate. The titers represent
the averages obtained from triplicate experiments. The error bars
indicate the standard deviation. Some error bars are not evident
because the standard deviation bar is less than or equal to the height
of the symbols.
|
|
Attenuated virulence and deficient growth of recombinant virus
RvM27 in immunodeficient SCID mice.
Immunodeficient animals have
been shown to be extremely susceptible to MCMV infection (18, 34,
36, 39). For example, CB17 SCID mice, which lack functional T
and B lymphocytes, are sensitive to low levels of viral replication, as
these animals succumb to as little as 10 PFU of MCMV (34,
36). Analysis of viral replication in these mice serves as an
excellent model for comparing the virulence of different MCMV strains
and mutants and for studying how they cause opportunistic
infections in immunocompromised hosts. To determine whether the
M27 open reading frame plays a significant role in MCMV virulence, the
survival rates of animals infected with RvM27 were determined and
compared to those of animals infected with RqM27 and the wild-type
Smith strain. The viral inocula used for the infection of animals were
prepared by growing the viruses in NIH 3T3 cells. For each virus, five
SCID mice were injected intraperitoneally with 104 PFU of
RvM27, RqM27, or the Smith strain. All the mice that were infected with
either strain Smith or RqM27 died within 25 to 26 days postinfection
(Fig. 5). In contrast, no animals
infected with RvM27 died until 37 days postinfection (Fig. 5). This
observation indicated that RvM27 was attenuated in viral virulence in
killing SCID mice. It has recently been demonstrated in our laboratory that the presence of the transposon sequence per se within the viral
genome does not significantly affect MCMV virulence in killing SCID
mice (57). Thus, these results suggest that disruption of
the M27 open reading frame diminishes viral virulence and that M27
plays an important role in MCMV virulence in SCID mice.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
Mortality of SCID mice infected with strain Smith, (WT),
RvM27, and RqM27. CB17 SCID mice (five animals per group) were infected
intraperitoneally with 104 PFU of each virus. Mortality of
mice was monitored for at least 41 days postinfection, and survival
rates were determined.
|
|
To further study the pathogenesis of the mutant virus in these
immunodeficient animals, the replication of RvM27 in different
organs
of the animals was studied during a 21-day infection period
before the
onset of mortality of the infected animals. In these
experiments, SCID mice were injected intraperitoneally with
10
4 PFU of each virus (RvM27, RqM27, or the wild-type Smith
strain).
At 1, 3, 7, 10, 14, and 21 days postinfection, three mice from
each virus group were sacrificed, and the salivary glands, lungs,
spleens, livers, and kidneys were harvested. The levels of viral
growth
in these five organs were determined by assaying the viral
titers in
the organs. The titers of RqM27 in each of the organs
examined were
similar to those of the Smith strain (Fig.
6). In
contrast, the titers of the mutant
virus RvM27 were consistently
lower than those of the wild-type virus
at every time point examined.
At 21 days postinfection, the
titers of RvM27 in the salivary
glands, lungs, spleens, livers,
and kidneys of the infected animals
were lower than the titers of the
wild-type virus by 50-, 400-,
50-, 100-, and 50-fold, respectively
(Fig.
4). Therefore, RvM27
appears to grow poorly in the organs of the
immunodeficient animals.
Previous studies have shown that the presence
of the transposon
sequence per se within the viral genome does not
significantly
affect viral growth in SCID mice in vivo
(
57). Thus, these results
suggest that the attenuated
growth of RvM27 in these organs is
probably due to the disruption of
M27 and that open reading frame
M27 may be required for optimal growth
of MCMV in these organs
in immunodeficient hosts.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 6.
Titers of MCMV wild-type (WT) and mutants in the
salivary glands (A), lungs (B), spleens (C), livers (D), and kidneys
(E) of infected SCID mice. CB17 SCID mice were infected
intraperitoneally with 104 PFU of each virus. At 1, 3, 7, 10, 14, and 21 days postinfection, the animals (three mice per group)
were sacrificed. The salivary glands, lungs, spleens, livers, and
kidneys were collected and sonicated. The viral titers in the tissue
homogenates were determined by standard plaque assays in NIH 3T3 cells.
The limit of detection was 10 PFU/ml of tissue homogenate. The titers
represent the averages obtained from triplicate experiments. The error
bars indicate the standard deviation. Some error bars are not evident
because the standard deviation bar is less than or equal to the height
of the symbols.
|
|
Genome and transposon mutation of RvM27 are stable during viral
growth in SCID mice.
It has been found that some MCMV mutants with
an insertional sequence are not stable and generate spontaneous
mutations during replication in vitro and in vivo (2, 26)
(Abenes et al., unpublished results). It is possible that the
transposon sequence in RvM27 is not stable during the viral replication
in vivo and the introduction of an adventitious mutation may be
responsible for the observed phenotypes of the virus in animals. To
address this issue, the salivary glands and spleens of RvM27-infected SCID mice were harvested at 21 days postinfection. The viruses were
subsequently recovered from these organs by infecting NIH 3T3 cells
with the sonicated tissue homogenates. Viral DNAs were purified from
the infected cells, and their restriction digestion patterns were
analyzed in agarose gels. Figure 7 shows
a Southern analysis of the RvM27 viral DNAs with a DNA probe that
contained the transposon and the M27 open reading frame sequence. The
results showed that no change in the hybridization patterns of RvM27
occurred as a result of viral growth in animals for 21 days (lanes 1 to 4). Moreover, the overall HindIII digestion patterns of
RvM27 DNA isolated from either infected cultured cells or animals were identical to those of the original recombinant virus RvM27, as visualized by ethidium bromide staining of the viral DNAs (data not
shown). Thus, the transposon insertion in RvM27 appeared to be stable,
and the genome of RvM27 remained intact during replication in the
infected animals.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 7.
Stability of the genome and the transposon mutation of
RvM27 during replication in SCID mice. Viral DNAs were isolated from
cells that were infected with RvM27 (MOI of <0.01) and allowed to grow
in culture for 5 days (P0) (lane 3) or from cells that were infected
with the virus recovered from either the salivary glands (SG, lane 1)
or spleen (Sp, lane 2) of SCID mice at 21 days after intraperitoneal
inoculation with 104 PFU of RvM27. Southern analyses of the
viral DNA fractions digested with EcoRI are shown. The DNA
of the wild-type virus (WT) is shown in lane 4. The
32P-radiolabeled probe was derived from the same plasmid
which was used for Southern analyses of RvM27 in Fig. 1 and contained
the transposon and M27 open reading frame sequence.
|
|
 |
DISCUSSION |
In this study, we have characterized the virulence and growth of a
recombinant virus in vitro and in both immunocompetent BALB/c mice and
immunodeficient SCID mice. This viral mutant, RvM27, contained an
insertional mutation at open reading frame M27. Our results provide the
first direct evidence to suggest that disruption of the M27 open
reading frame results in attenuated virulence and reduced growth of the
virus in both BALB/c and SCID mice. Moreover, the results presented in
this study suggest that M27 functions in supporting efficient viral
replication in vivo and is required for optimal viral virulence in
immunodeficient hosts.
Our results indicate that the transposon sequence was inserted into the
M27 region and disrupted the coding sequence of the open reading frame
(Fig. 1B). Moreover, transcription from the region downstream from the
transposon insertion site was not detected in cells infected with the
mutant virus (Fig. 2). Thus, the region of the target open reading
frame downstream from the transposon insertion site, which includes the
3' M27 coding sequence, was not expressed. RvM27 replicated in vitro in
NIH 3T3 cells as well as the wild-type Smith strain and the rescued
virus RqM27 (Fig. 3). These results suggest that M27 is dispensable for
MCMV growth in vitro in NIH 3T3 cells.
MCMV infection in mice has been an excellent model for studies of CMV
infections in vivo and for providing insights in HCMV pathogenesis in
humans (19, 22, 29). For example, both MCMV and HCMV are
opportunistic pathogens and cause severe infections in immunodeficient
hosts (e.g., SCID mice and AIDS patients). In SCID mice, MCMV causes a
systemic infection and replicates efficiently in most of the organs
(see Fig. 6) (34, 36). The high viral titers in many of
the organs and the destruction of host cells and tissues by viral
infection usually lead to the death of the animals. The function of M27
is currently unknown. Indeed, to our knowledge, neither the transcript
nor the protein product coded by this open reading frame has been
extensively characterized. Our results indicate that a transcript of
about 3,000 nucleotides is expressed from the M27 open reading frame. RvM27 was found to be deficient in replication in the salivary glands,
lungs, spleens, livers, and kidneys of both BALB/c and SCID mice that
were intraperitoneally infected. For example, at 21 days postinfection,
the titers of RvM27 in the salivary glands, lungs, spleens, livers, and
kidneys of the infected SCID mice were lower than the titers of the
wild-type virus by 50-, 400-, 50-, 100-, and 50-fold, respectively
(Fig. 6). Moreover, no deaths occurred among SCID mice infected with
RvM27 for up to 37 days postinfection, while all of the mice infected
with the Smith strain or RqM37 died within 26 days postinfection (Fig.
5). These results strongly suggest that M27 is a viral determinant for
MCMV growth in vivo in these animals and for viral virulence in killing
SCID mice.
It is possible that the observed change in the level of replication of
the mutant is due to adventitious mutations introduced during the
construction and growth of the recombinant virus in cultured cells or
in animals. However, several lines of evidence strongly suggest that
this is unlikely. First, the wild-type phenotypes for growth and
virulence in the infected mice were restored in RqM27 upon restoration
of the wild-type sequence into RvM27 (Fig. 1, 4, 5, and 6).
Furthermore, the restoration of the wild-type phenotypes in RqM27
occurred together with the restoration of M27 expression (Fig. 2).
These observations suggest that the transposon insertion rather than an
adventitious mutation is responsible for the observed attenuation of
RvM27 replication and virulence in vivo. Second, our previous studies
indicated that a virus mutant (Rvm09) with a transposon insertion at
the m09 open reading frame replicated as well in both BALB/c and SCID
mice as the wild-type virus (57). Moreover, mutant Rvm09
exhibited a level of virulence in killing SCID mice similar to the
wild-type virus. These observations indicated that the transposon
sequence per se in the viral genome does not significantly affect viral
replication and virulence in the infected animals (57).
Third, the genome and the transposon insertion in the viral mutant were
stable during replication in animals. There was no change in the
hybridization patterns of the DNAs from the mutant viruses that were
recovered from the salivary glands and spleens of the infected animals
after 21 days of infection (Fig. 7 and data not shown). Moreover, the
HindIII digestion patterns of the RvM27 mutant DNAs,
other than the transposon insertion region, appeared to be identical to
those of the wild-type virus DNA (data not shown). Thus, the observed
change in the level of RvM27 replication and virulence in the infected
mice is probably due to the disruption of M27 expression as a result of
the transposon insertion.
A transposon insertion mutagenesis approach, as demonstrated
successfully by many other laboratories, is convenient for identifying gene functions in viral, bacterial, and yeast systems, especially when
little is known about the genes and their functions. Results presented
in this study as well as in our other recent studies (56,
57) further demonstrate that the Tn3 system can be
used for simultaneous isolation of multiple viral mutants and may have advantages over traditional homologous recombination system for systematic generation of viral mutants. Each of these viral mutants contained a transposon insert of ~3.6 kb, since the transposon sequence includes the selection marker genes coding for both the gpt and tetracycline resistance functions. These two markers
were used for selection of the transposon-containing sequence in
E. coli and in mammalian cell cultures. Viral mutants
containing more subtle mutations (e.g., single point mutations in M27)
can be generated from our transposon-containing mutants by traditional homologous recombination and selection against gpt
expression, in a procedure similar to that used for the construction of
RqM27. Further characterization of these mutants will facilitate the identification of the functional domains of M27 important for viral
virulence and growth in vivo.
Homologues of M27 have been found in animal and human betaherpesviruses
(e.g., rat CMV and HCMV) but not in alpha- and gammaherpesviruses (e.g., herpes simplex virus and Epstein-Barr virus) (7, 13, 16,
20, 27, 29, 33, 38, 41, 53). For example, M27 (38)
has sequence homology with UL27 of HCMV (7), R27 of rat
CMV (53), and U5/U7 of human herpesviruses 6 and 7 (13, 16, 20, 27, 33). The high degree of conservation of
this open reading frame among animal and human CMVs suggests that the functions of M27 and its homologues are important in the pathogenesis and virulence of these viruses in vivo (7, 38, 53).
Meanwhile, the low degree of sequence homology of these M27 homologues
with genes found in other herpesviruses as well as in other organisms and hosts in the database suggest that their functions are unique in
infections with these betaherpesviruses (7, 38, 53) (M. Lee, A. McGregor, G. Abenes, and F. Liu, unpublished results). The
function of UL27 as well as other M27 homologues (e.g., R27 of rat CMV)
is currently unknown. Indeed, to our knowledge, the products coded by
these open reading frames have not been reported or characterized. Our
results in this study provide the first direct evidence to suggest that
M27 plays a significant role in MCMV virulence and growth in both
immunocompetent BALB/c mice and immunodeficient SCID mice. It will be
interesting to determine whether UL27 and other M27 homologues are also
dispensable for viral replication in vitro and are also required for
optimal viral growth and virulence in vivo. These studies will reveal
whether these highly conserved open reading frames have similar
functions in the pathogenesis and virulence of CMVs and betaherpesviruses.
A key question arising from our results is how the lack of a protein,
such as M27, leads to a change in the level of viral growth and
virulence. Very few viral mutants that contain a mutation at a single
locus in the viral genome have been characterized for their growth and
virulence in both BALB/c and SCID mice. Attempts have been made to
compare the in vivo phenotypes of RvM27 with the phenotypes of other
viral mutants, including those that were generated in our
laboratory by transposon insertion at different loci of the viral
genome (G. Abenes, M. Lee, J. Xiao, E. Haghjoo, T. Tuong, J. Kim,
A. Tam, W. Dunn, X. Zhan, and F. Liu, unpublished results). These
results revealed that the levels of attenuation in the growth and
virulence of RvM27 in the infected animals are very similar to those of
the viral mutants that contain a transposon mutation or a deletion in
the M83 open reading frame, which encodes one of the most abundant
viral tegument proteins (9, 31, 57). However, there is
currently no evidence to suggest that the CMV virion or tegument
contains UL27/M27 proteins (1). Moreover, the function of
M83 as well as UL83 in vivo is currently not completely understood.
Equally elusive is the mechanism of how the viral mutants with
mutations at M83 diminished their growth and virulence in vivo.
It is possible that a viral mutant disrupted in M83 or M27, while
capable of replicating normally in NIH 3T3 fibroblasts, is deficient in
its ability to spread to the target organs, to enter permissive cells,
or to replicate in cells of particular organs or tissues in the
infected animals. More detailed studies on the in vitro and in vivo
growth of these mutants will reveal whether M27 functions similarly to
M83 in supporting optimal growth and virulence of MCMV in vivo. These
studies, along with studies of other viral mutants exhibiting similar
phenotypes, will lead to identification of the viral determinants for
optimal growth and virulence in vivo and will provide insights into how these determinants function in CMV pathogenesis and infection.
 |
ACKNOWLEDGMENTS |
We thank Edward Mocarski of Stanford University for helpful
discussions and Michael Snyder of Yale University for providing the
Tn3 transposon constructs and the E. coli strains
for transposon shuttle mutagenesis.
M.L. is a recipient of the predoctoral dissertation fellowship of the
State of California AIDS research program (D00-B-105). E.H.
acknowledges fellowship support from the Biology Fellow program (University of California-Berkeley). F.L. is a Pew Scholar in Biomedical Sciences and a recipient of a Basil O'Connor Starter Scholar Research Award (March of Dimes National Birth Defects Foundation) and a Regents Junior Faculty Fellowship (University of
California). This research was supported in part by a Chancellor's Special Initiative Grant Award (University of
California-Berkeley).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Program in
Infectious Diseases and Immunity, School of Public Health, 140 Warren
Hall, University of California, Berkeley, CA 94720. Phone: (510)
643-2436. Fax: (510) 642-6350. E-mail:
liu_fy{at}uclink4.berkeley.edu.
 |
REFERENCES |
| 1.
|
Baldick, C. J., Jr., and T. Shenk.
1996.
Proteins associated with purified human cytomegalovirus particles.
J. Virol.
70:6097-6105[Abstract].
|
| 2.
|
Boname, J. M., and J. K. Chantler.
1992.
Characterization of a strain of murine cytomegalovirus which fails to grow in the salivary glands of mice.
J. Gen. Virol.
73:2021-2029[Abstract/Free Full Text].
|
| 3.
|
Borst, E.,
G. Hahn,
U. H. Koszinowski, and M. Messerle.
1999.
Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial chromosome in Escherichia coli: a new approach for construction of HCMV mutants.
J. Virol.
73:8320-8329[Abstract/Free Full Text].
|
| 4.
|
Britt, W. J., and C. A. Alford.
1996.
Cytomegalovirus, p. 2493-2523.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields Virology, 3rd ed. Raven Press, New York, N.Y.
|
| 5.
|
Brune, W.,
C. Menard,
U. Hobom,
S. Odenbreit,
M. Messerle, and U. H. Koszinowski.
1999.
Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis.
Nat. Biotechnol.
17:360-364[CrossRef][Medline].
|
| 6.
|
Burns, N.,
B. Grimwade,
P. B. Ross-Macdonald,
E. Y. Choi,
K. Finberg,
G. S. Roeder, and M. Snyder.
1994.
Large-scale analysis of gene expression, protein localization, and gene disruption in Saccharomyces cerevisiae.
Genes Dev.
8:1087-1105[Abstract/Free Full Text].
|
| 7.
|
Chee, M. S.,
A. T. Bankier,
S. Beck,
R. Bohni,
C. M. Brown,
R. Cerny,
T. Horsnell,
C. A. Hutchison,
T. Kouzarides, and J. A. Martignetti.
1990.
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
Curr. Top. Microbiol. Immunol.
154:125-169[Medline].
|
| 8.
|
Cohen, J. I., and K. E. Seidel.
1993.
Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.
Proc. Natl. Acad. Sci. USA
90:7376-7380[Abstract/Free Full Text].
|
| 9.
|
Cranmer, L. D.,
C. L. Clark,
C. S. Morello,
H. E. Farrell,
W. D. Rawlinson, and D. H. Spector.
1996.
Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.
J. Virol.
70:7929-7939[Abstract].
|
| 10.
|
Cunningham, C., and A. J. Davison.
1993.
A cosmid-based system for constructing mutants of herpes simplex virus type 1.
Virology
197:116-124[CrossRef][Medline].
|
| 11.
|
Dallas, P. B.,
P. A. Lyons,
J. B. Hudson,
A. A. Scalzo, and G. R. Shellam.
1994.
Identification and characterization of a murine cytomegalovirus gene with homology to the UL25 open reading frame of human cytomegalovirus.
Virology
200:643-650[CrossRef][Medline].
|
| 12.
|
Delecluse, H. J.,
T. Hilsendegen,
D. Pich,
R. Zeidler, and W. Hammerschmidt.
1998.
Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.
Proc. Natl. Acad. Sci. USA
95:8245-8250[Abstract/Free Full Text].
|
| 13.
|
Dominguez, G.,
T. R. Dambaugh,
F. R. Stamey,
S. Dewhurst,
N. Inoue, and P. E. Pellett.
1999.
Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A.
J. Virol.
73:8040-8052[Abstract/Free Full Text].
|
| 14.
|
Fowler, K. B.,
S. Stagno,
R. F. Pass,
W. J. Britt,
T. J. Boll, and C. A. Alford.
1992.
The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.
N. Engl. J. Med.
326:663-667[Abstract].
|
| 15.
|
Gallant, J. E.,
R. D. Moore,
D. D. Richman,
J. Keruly, and R. E. Chaisson.
1992.
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine.
J. Infect. Dis.
166:1223-1227[Medline].
|
| 16.
|
Gompels, U. A.,
J. Nicholas,
G. Lawrence,
M. Jones,
B. J. Thomson,
M. E. Martin,
S. Efstathiou,
M. Craxton, and H. A. Macaulay.
1995.
The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution.
Virology
209:29-51[CrossRef][Medline].
|
| 17.
|
Greaves, R. F.,
J. M. Brown,
J. Vieira, and E. S. Mocarski.
1995.
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene.
J. Gen. Virol.
76:2151-2160[Abstract/Free Full Text].
|
| 18.
|
Grundy, J. E., and C. J. Melief.
1982.
Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus.
J. Gen. Virol.
61:133-136[Abstract/Free Full Text].
|
| 19.
|
Hudson, J. B.
1979.
The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.
Arch. Virol.
62:1-29[CrossRef][Medline].
|
| 20.
|
Isegawa, Y.,
T. Mukai,
K. Nakano,
M. Kagawa,
J. Chen,
Y. Mori,
T. Sunagawa,
K. Kawanishi,
J. Sashihara,
A. Hata,
P. Zou,
H. Kosuge, and K. Yamanishi.
1999.
Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B.
J. Virol.
73:8053-8063[Abstract/Free Full Text].
|
| 21.
|
Jenkins, F. J.,
M. J. Casadaban, and B. Roizman.
1985.
Application of the mini-Mu-phage for target-sequence-specific insertional mutagenesis of the herpes simplex virus genome.
Proc. Natl. Acad. Sci. USA
82:4773-4777[Abstract/Free Full Text].
|
| 22.
|
Jordan, M. C.
1983.
Latent infection and the elusive cytomegalovirus.
Rev. Infect. Dis.
5:205-215[Medline].
|
| 23.
|
Kemble, G.,
G. Duke,
R. Winter, and R. Spaete.
1996.
Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids.
J. Virol.
70:2044-2048[Abstract].
|
| 24.
|
Liu, F., and B. Roizman.
1991.
The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate.
J. Virol.
65:5149-5156[Abstract/Free Full Text].
|
| 25.
|
Liu, F. Y., and B. Roizman.
1991.
The promoter, transcriptional unit, and coding sequence of herpes simplex virus 1 family 35 proteins are contained within and in frame with the UL26 open reading frame.
J. Virol.
65:206-212[Abstract/Free Full Text].
|
| 26.
|
Manning, W. C.,
C. A. Stoddart,
L. A. Lagenaur,
G. B. Abenes, and E. S. Mocarski.
1992.
Cytomegalovirus determinant of replication in salivary glands.
J. Virol.
66:3794-3802[Abstract/Free Full Text].
|
| 27.
|
Megaw, A. G.,
D. Rapaport,
B. Avidor,
N. Frenkel, and A. J. Davison.
1998.
The DNA sequence of the RK strain of human herpesvirus 7.
Virology
244:119-132[CrossRef][Medline].
|
| 28.
|
Messerle, M.,
I. Crnkovic,
W. Hammerschmidt,
H. Ziegler, and U. H. Koszinowski.
1997.
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.
Proc. Natl. Acad. Sci. USA
94:14759-14763[Abstract/Free Full Text].
|
| 29.
|
Mocarski, E. S.
1996.
Cytomegaloviruses and their replication, p. 2447-2492.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields Virology, 3rd ed. Raven Press, New York, N.Y.
|
| 30.
|
Mocarski, E. S.,
L. E. Post, and B. Roizman.
1980.
Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions.
Cell
22:243-255[CrossRef][Medline].
|
| 31.
|
Morrello, C. S.,
L. D. Cranmer, and D. H. Spector.
1999.
In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83).
J. Virol.
73:7678-7693[Abstract/Free Full Text].
|
| 32.
|
Mulligan, R. C., and P. Berg.
1981.
Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.
Proc. Natl. Acad. Sci. USA
78:2072-2076[Abstract/Free Full Text].
|
| 33.
|
Nicholas, J.
1996.
Determination and analysis of the complete nucleotide sequence of human herpesvirus.
J. Virol.
70:5975-5989[Abstract].
|
| 34.
|
Okada, M., and Y. Minamishima.
1987.
The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice.
Microbiol. Immunol.
31:45-57[Medline].
|
| 35.
|
Palella, F. J., Jr.,
K. M. Delaney,
A. C. Moorman,
M. O. Loveless,
J. Fuhrer,
G. A. Satten,
D. J. Aschman, and S. D. Holmberg.
1998.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.
N. Engl. J. Med.
338:853-860[Abstract/Free Full Text].
|
| 36.
|
Pollock, J. L., and H. W. Virgin, IV.
1995.
Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.
J. Virol.
69:1762-1768[Abstract].
|
| 37.
|
Post, L. E., and B. Roizman.
1981.
A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.
Cell
25:227-232[CrossRef][Medline].
|
| 38.
|
Rawlinson, W. D.,
H. E. Farrell, and B. G. Barrell.
1996.
Analysis of the complete DNA sequence of murine cytomegalovirus.
J. Virol.
70:8833-8849[Abstract].
|
| 39.
|
Reynolds, R. P.,
R. J. Rahija,
D. I. Schenkman, and C. B. Richter.
1993.
Experimental murine cytomegalovirus infection in severe combined immunodeficient mice.
Lab. Anim. Sci.
43:291-295[Medline].
|
| 40.
|
Roizman, B., and F. J. Jenkins.
1985.
Genetic engineering of novel genomes of large DNA viruses.
Science
229:1208-1214[Abstract/Free Full Text].
|
| 41.
|
Roizman, B., and A. E. Sears.
1996.
Herpes simplex viruses and their replication, p. 2231-2296.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields Virology, 3rd ed. Raven Press, New York, N.Y.
|
| 42.
|
Ross-Macdonald, P.,
P. S. Coelho,
T. Roemer,
S. Agarwal,
A. Kumar,
R. Jansen,
K. H. Cheung,
A. Sheehan,
D. Symoniatis,
L. Umansky,
M. Heidtman,
F. K. Nelson,
H. Iwasaki,
K. Hager,
M. Gerstein,
P. Miller,
G. S. Roeder, and M. Snyder.
1999.
Large-scale analysis of the yeast genome by transposon tagging and gene disruption.
Nature
402:413-418[CrossRef][Medline].
|
| 43.
|
Saeki, Y.,
T. Ichikawa,
A. Saeki,
E. A. Chiocca,
K. Tobler,
M. Ackermann,
X. O. Breakefield, and C. Fraefel.
1998.
Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
Hum. Gene Ther.
9:2787-2794[Medline].
|
| 44.
|
Seifert, H. S.,
E. Y. Chen,
M. So, and F. Heffron.
1986.
Shuttle mutagenesis: a method of transposon mutagenesis for Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
83:735-739[Abstract/Free Full Text].
|
| 45.
|
Selik, R. M.,
S. Y. Chu, and J. W. Ward.
1995.
Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992.
Ann. Intern. Med.
123:933-936[Abstract/Free Full Text].
|
| 46.
|
Selik, R. M.,
J. M. Karon, and J. W. Ward.
1997.
Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993.
J. Infect. Dis.
176:632-636[Medline].
|
| 47.
|
Smith, G. A., and L. W. Enquist.
1999.
Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus.
J. Virol.
73:6405-6414[Abstract/Free Full Text].
|
| 48.
|
Smith, G. A., and L. W. Enquist.
2000.
A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis.
Proc. Natl. Acad. Sci. USA
97:4873-4878[Abstract/Free Full Text].
|
| 49.
|
Stavropoulos, T. A., and C. A. Strathdee.
1998.
An enhanced packaging system for helper-dependent herpes simplex virus vectors.
J. Virol.
72:7137-7143[Abstract/Free Full Text].
|
| 50.
|
Tomkinson, B.,
E. Robertson,
R. Yalamanchili,
R. Longnecker, and E. Kieff.
1993.
Epstein-Barr virus recombinants from overlapping cosmid fragments.
J. Virol.
67:7298-7306[Abstract/Free Full Text].
|
| 51.
|
van Zijl, M.,
W. Quint,
J. Briaire,
T. de Rover,
A. Gielkens, and A. Berns.
1988.
Regeneration of herpesviruses from molecularly cloned subgenomic fragments.
J. Virol.
62:2191-2195[Abstract/Free Full Text].
|
| 52.
|
Vieira, J.,
H. E. Farrell,
W. D. Rawlinson, and E. S. Mocarski.
1994.
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette.
J. Virol.
68:4837-4846[Abstract/Free Full Text].
|
| 53.
|
Vink, C.,
E. Beuken, and C. A. Bruggeman.
2000.
Complete DNA sequence of the rat cytomegalovirus genome.
J. Virol.
74:7656-7665[Abstract/Free Full Text].
|
| 54.
|
Wagner, M.,
S. Jonjic,
U. H. Koszinowski, and M. Messerle.
1999.
Systematic excison of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.
J. Virol.
73:7056-7060[Abstract/Free Full Text].
|
| 55.
|
Weber, P. C.,
M. Levine, and J. C. Glorioso.
1987.
Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis.
Science
236:576-579[Abstract/Free Full Text].
|
| 56.
|
Zhan, X.,
G. Abenes,
M. Lee,
I. VonReis,
C. Kittinunvorakoon,
P. Ross-Macdonald,
M. Snyder, and F. Liu.
2000.
Mutagenesis of murine cytomegalovirus using a Tn3-based transposon.
Virology
266:264-274[CrossRef][Medline].
|
| 57.
|
Zhan, X.,
M. Lee,
J. Xiao, and F. Liu.
2000.
Construction and characterization of murine cytomegaloviruses that contain a transposon insertion at open reading frames m09 and M83.
J. Virol.
74:7411-7421[Abstract/Free Full Text].
|
Journal of Virology, February 2001, p. 1697-1707, Vol. 75, No. 4
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.4.1697-1707.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Le, V. T. K., Trilling, M., Wilborn, M., Hengel, H., Zimmermann, A.
(2008). Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J. Gen. Virol.
89: 2416-2426
[Abstract]
[Full Text]
-
Kulesza, C. A., Shenk, T.
(2006). Murine cytomegalovirus encodes a stable intron that facilitates persistent replication in the mouse. Proc. Natl. Acad. Sci. USA
103: 18302-18307
[Abstract]
[Full Text]
-
Zimmermann, A., Trilling, M., Wagner, M., Wilborn, M., Bubic, I., Jonjic, S., Koszinowski, U., Hengel, H.
(2005). A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. JEM
201: 1543-1553
[Abstract]
[Full Text]
-
Chou, S., Marousek, G. I., Senters, A. E., Davis, M. G., Biron, K. K.
(2004). Mutations in the Human Cytomegalovirus UL27 Gene That Confer Resistance to Maribavir. J. Virol.
78: 7124-7130
[Abstract]
[Full Text]
-
Komazin, G., Ptak, R. G., Emmer, B. T., Townsend, L. B., Drach, J. C.
(2003). Resistance of Human Cytomegalovirus to the Benzimidazole L-Ribonucleoside Maribavir Maps to UL27. J. Virol.
77: 11499-11506
[Abstract]
[Full Text]
-
van den Pol, A. N., Reuter, J. D., Santarelli, J. G.
(2002). Enhanced Cytomegalovirus Infection of Developing Brain Independent of the Adaptive Immune System. J. Virol.
76: 8842-8854
[Abstract]
[Full Text]